Contract W81K0025PA125

Diasorin Inc · Department Of Defense · July 25, 2025

Firm Fixed PriceSole SourceNAICS 325413

Diasorin Inc was awarded a federal contract by Department Of Defense (Department Of The Army) on July 25, 2025 for $923,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Jbsa Ft Sam Houston, TX. It was awarded under full and open competition. The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 17, 2025. If all options are exercised, the contract could reach $4.61 million.

Obligated to date
$922.9K
$922,946
Current value
$922.9K
Potential value
$4.61M
if all options exercised
Modifications
2
Latest December 17, 2025

Contract details

PIID
W81K0025PA125
Award type
Purchase Order
Pricing
Firm Fixed Price
Set-aside
No Set Aside Used.
Competition
Not Competed
NAICS
325413 · In-Vitro Diagnostic Substance Manufacturing
Product / service
In Vitro Diagnostic Substances, Reagents, Test Kits And Sets
Place of performance
Jbsa Ft Sam Houston, TX
First action
July 25, 2025
Latest action
December 17, 2025

Description

IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR PURCHASE ORDER W81K00-25-P-A125 FOR THE PERIOD OF 1 OCTOBER

Modification timeline

  • December 17, 2025
    Mod P00002
    IN ACCORDANCE WITH FEDERAL ACQUISITION REGULATION (FAR) 52.232-18, AVAILABILITY OF FUNDS, FY26 FUNDS ARE AVAILABLE AND HEREBY OBLIGATED FOR PURCHASE ORDER W81K0
    $922.9K
  • December 16, 2025
    Mod P00001
    THIS IS AN ADMINISTRATIVE MODIFICATION TO DELIVERY ORDER W81K00-25-P-A125 TO REMOVE THE PAYMENT OFFICE INFORMATION DUE TO THE HS2 FUNDS VALIDATION ERROR.
    $0
  • July 25, 2025
    Base award
    THE GOVERNMENTS REQUIREMENT IS TO ESTABLISH A COST-PER-KIT AGREEMENT TO INCLUDE REAGENTS, CONSUMABLES, CONTROLS, AND ANY NECESSARY PRODUCTS TO CONDUCT ALL REQUI
    $0

Similar contracts

RecipientAgencyDateObligated
Diasorin IncDepartment Of DefenseDecember 31, 2025$518.8K
BloodworksDepartment Of DefenseDecember 31, 2025$160.2K
Sl Meditech Co.Department Of DefenseDecember 31, 2025$151.6K
Alba Bioscience, Inc.Department Of DefenseDecember 31, 2025$163.2K
Werfen USA LlcDepartment Of DefenseDecember 31, 2025$18.1K
Immucor IncDepartment Of DefenseDecember 31, 2025$154.2K

Top contractors in NAICS 325413

Lifetime obligated dollars across all federal contracts in this NAICS code.

#ContractorContractsObligated
1Abbott Rapid Dx North America Llc651$3.51B
2Ihealth Labs Inc.4$2.13B
3Roche Diagnostics Corporation5,604$959.60M
4Siemens Healthcare Diagnostics Inc.818$641.45M
5Cepheid3,693$639.45M
6Remel Inc.4,525$464.47M
7Access Bio, Inc.5$340.72M
8Ortho-Clinical Diagnostics, Inc1,964$227.77M
9Quidel Corp96$194.78M
10Ortho-Clinical Diagnostics Inc2,494$183.46M

Track this on BesaGov

Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.

✓ You’re on the list. We’ll never spam you.

Helpful guides

Continue learning

See all guides →
More on BesaGov

Keep researching

Track this contract, set alerts on similar opportunities, and build proposal pipelines on BesaGov.
Sign up free

Frequently asked questions

What is contract W81K0025PA125?

Contract W81K0025PA125 is a federal contract awarded to Diasorin Inc by Department Of Defense on July 25, 2025 for $923,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 2 times since the base award.

Who won contract W81K0025PA125?

Diasorin Inc won contract W81K0025PA125 from Department Of Defense.

How much is contract W81K0025PA125 worth?

Contract W81K0025PA125 has obligated $923,000 to date, with a total potential value of $4.61 million if all options are exercised.